AMP kinase: A promising therapeutic drug target for post-COVID-19 complications.
Coronavirus Literature
Publication date: Nov 01, 2024 The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in severe respiratory issues and persistent complications, particularly affecting glucose metabolism. Patients with or without pre-existing diabetes ... Read more